Economist, strategist and senior advisor to many of the world’s largest health and pharmaceutical companies, Robert was formerly director of corporate strategy and of public affairs at Glaxo Wellcome plc. He has been Chairman of the Economic Policy Committee of the European pharmaceutical industry federation, is actively involved as a strategic advisor in the industry, and has authored over 20 published articles.

